4//SEC Filing
Balo Andrew K 4
Accession 0001093557-22-000045
CIK 0001093557other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 7:22 PM ET
Size
10.7 KB
Accession
0001093557-22-000045
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Balo Andrew K
SVP, Regulatory and Clinical
Transactions
- Disposition to Issuer
Common Stock
2022-03-09$406.06/sh−932$378,445→ 18,113 total - Disposition to Issuer
Common Stock
2022-03-09$406.06/sh−1,549$628,982→ 16,564 total - Disposition to Issuer
Common Stock
2022-03-09$406.06/sh−949$385,348→ 15,615 total - Award
Common Stock
2022-03-08$0.00/sh+4,984$5→ 19,045 total
Holdings
- 7,553(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
- [F2]Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023.
- [F3]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F4]Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001323190
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 7:22 PM ET
- Size
- 10.7 KB